Non-Hodgkin lymphomas (NHLs) are a biologically and clinically diverse group of lymphoproliferative disorders. This learning program is designed to introduce you to indolent NHL. It will cover the pathology and classification of NHL in general, before addressing the epidemiology, diagnosis, and clinical management of the indolent types of NHL in more detail.
As you progress through the program, you will also follow the case of Tony Jobs, a 65-year-old carpenter suffering from indolent NHL.
Upon completion of this learning program, you will be able to::
Identify the common types of aggressive and indolent NHL.
Recall the epidemiology and etiology of indolent NHL.
Outline the necessary steps in the diagnosis of indolent NHL.
Describe the treatment options available for the management of indolent NHL.
PATHOLOGY AND CLASSIFICATION OF NHL
CELLULAR ORIGINS OF NHL – B CELLS, T CELLS, AND NK CELLS
Popup: WHO Classification I
Popup: WHO Classification II
Popup: WHO Classification III
Popup: Molecular Genetics of NHL
Popup: Most Common Aggressive NHLs
Popup: Naive B Cells
Popup: B Blasts and Centroblasts
Popup: Marginal Zone B Cells
Marginal Zone Lymphoma
Side Note: Digging Deeper
Rare Indolent NHL
EPIDEMIOLOGY AND ETIOLOGY OF INDOLENT NHL
INCIDENCE OF INDOLENT NHL
ETIOLOGY OF INDOLENT NHL
Popup: Other Risk Factors for NHL
DIAGNOSIS AND PROGNOSIS OF INDOLENT NHL
CLINICAL PRESENTATION AND DIAGNOSIS
Presentation and Physical Examination
Popup: Laboratory Tests
Popup: Diagnostic Imaging
Popup: Transformation to Aggressive Lymphoma
CLINICAL MANAGEMENT OF INDOLENT NHL
Popup: Common Chemotherapeutic Agents
HEMATOPOIETIC STEM CELL TRANSPLANTATION
TEST YOUR ACQUIRED KNOWLEDGE
END OF PROGRAM
This course is accredited for continuing education (CE) by the following organizations:
Australian Nursing & Midwifery Federation
CPD Hours: 1.5